Press Releases
Samsung Biologics to showcase strengthened development capabilities and business expansion updates at CPHI 2023
Samsung Biologics will be attending CPHI Barcelona between October 24-26 as the event’s official registration
and welcome partner.
As a trusted CDMO partner, the company will demonstrate how its strengthened chemical, manufacturing, and control (CMC) solution packages and new proprietary development platforms – S-KiH and S-GlynTM – can accelerate clients’ drug development journey and maximize the potential of their molecule.
Samsung Biologics will also share its latest expansion plans regarding the construction of its new Plant 5, the first facility of its second Bio Campus at their Songdo headquarters. When operational by April 2025, the company will continue to hold the world’s largest manufacturing capacity with 784,000 liters.
Samsung Biologics is also adding an antibody-drug conjugate (ADC) facility, which is expected to be CGMP-ready within 2024.
As part of its ongoing sustainability efforts, the company has built an eco-friendly booth with reusable materials and reduced waste by incorporating QR technology within the booth.
Meet the Samsung Biologics team at Booth #3K40 or schedule a meeting here
Samsung Biologics will be attending CPHI Barcelona between October 24-26 as the event’s official registration
and welcome partner.
As a trusted CDMO partner, the company will demonstrate how its strengthened chemical, manufacturing, and control (CMC) solution packages and new proprietary development platforms – S-KiH and S-GlynTM – can accelerate clients’ drug development journey and maximize the potential of their molecule.
Samsung Biologics will also share its latest expansion plans regarding the construction of its new Plant 5, the first facility of its second Bio Campus at their Songdo headquarters. When operational by April 2025, the company will continue to hold the world’s largest manufacturing capacity with 784,000 liters.
Samsung Biologics is also adding an antibody-drug conjugate (ADC) facility, which is expected to be CGMP-ready within 2024.
As part of its ongoing sustainability efforts, the company has built an eco-friendly booth with reusable materials and reduced waste by incorporating QR technology within the booth.
Meet the Samsung Biologics team at Booth #3K40 or schedule a meeting here